Billion Dollar Moves™ with Sarah Chen-Spellings · 2026-04-30 · 47 min
In this episode of Billion Dollar Moves, I sit down with David Berry, Co-Founder and Managing Partner of Averin Capital, for a conversation about building billion-dollar breakthroughs in healthcare. David has founded more than 30 companies, including seven valued over $1B, and has helped shape companies across biotech, AI drug discovery, microbiome therapeutics, agriculture, and health infrastructure. From losing a childhood friend to brain cancer, to asking why the hardest problems are worth pursuing, David shares how mission, science, and capital come together to create venture-scale healthcare companies. For founders, funders, and family offices investing in the future of health, this is a conversation about conviction, ethics, and building for impact at scale. Watch the full conversation and subscribe for more discussions at the intersection of capital, governance, and long-term wealth. 00:00 - Intro: Why go after the biggest problems? 01:12 - Truth vs. belief in science 03:00 - The myth that humans only use 10% of their brains 04:28 - Rethinking cancer and inherited assumptions 05:38 - How big ideas emerge from questioning “truth” 06:30 - Entrepreneur vs.
How Midday Squares Is Building a Billion Dollar Brand Through Community, Chaos & Conviction | Jake Karls71 / 100She Built a Billion-Dollar Company - Then Learned When to Walk Away | Suneera MadhaniFrom Preserving Wealth to Investing Globally | Erika Aquino on Billion Dollar Moves
Building Cultural Capital & Leadership Lessons from Jeff Bezos | Latasha Gillespie on Billion Dollar Moves
$22M Exit & Buyback | Jaclyn Johnson, Founder, Create & Cultivate & Co-Founder, Cherub